A. Characteristics
- Usually occurs in Type 1 Diabetes with insufficient insulin
- DKA is often the initial presentation of DM Type 1
- DKA less common but may occur in Type 2 DM
- About 20% of DM2 in African-American and Hispanic persons includes ketosis and may present with diabetic ketoacidosis (DKA) [2]
- Diagnostic Criteria for Diabetic Ketoacidosis (DKA)
- Glucose >250mg/dL
- pH <7.35
- Low bicarbonate (<18mM)
- High anion gap
- Positive serum ketones
- Symptoms
- Volume Loss: Polyuria, Polydipsia, Weakness, Tachycardia
- Acidosis: Tachypnea (Kussmaul Respiration), drowsiness, nausea (with vomiting), coma
- Inefficient glucose utilization: drowsiness, tachycardia, diaphoresis
- Differential of Ketoacidosis
- Urinary ketones found in diabetes mellitus, alcoholism and starvation
- Serum ketones usually not seen in starvation unless very severe
- Always consider underlying alcohol abuse in new DKA
B. Precipitants of DKA
- Always evaluate patients for underlying precipitant of DKA
- In many cases, poor compliance with insulin therapy leads to DKA [3,4]
- Other precipitants cause an increase in counter-regulatory hormones
- These stress hormones are released in infection, hypovolemia, diet changes, etc.
- Stress hormones include epinephrine, cortisol, glucagon, norepinephrine, growth hormone
- Classes of Precipitants
- Noncompliance with insulin - often associated with substance abuse [3]
- Infection - most commonly of urinary tract in women (UTI)
- Ischemia - particularly with longstanding diabetes
- Myocardial Infarction
- Common precipitant and/or complication of DKA or hyperosmolar glycemic episode
- All DKA patients should have an ECG, most should be ruled out by serum enzymes
C. Pathophysiology of DKA
- Lack of insulin with increased glucagon leads to decreased glucose utilization
- This causes serum hyperglycemia with renal losses as glucosuria
- Low insulin and high glucagon fail to suppress lipolysis
- This leads to elevated fatty acids in blood with conversion to ketones and ketoacids
- The ketoacids cause an anion gap acidosis which leads to compensitory tachypnea
- Glucosuria causes an osmotic diuresis leading to hypovolemia
- The combination of acidosis and hypovolemia causes worsening tissue perfusion
- Acidosis, hypoperfusion eventually cause shock and hyperosmolar, ketotic, acidotic state
- Hypersecretion of glucagon now thought to potentiate each of these problems
D. Initial Evaluation
- Rapid history
- Fingerstick glucose
- Urinalyses
- Dipstick urine for glucose and ketones
- Urine specific gravity, sodium and creatinine levels for volume evaluation
- Serum Analyses
- Electrolytes and renal function (BUN, Creatinine)
- Calcium, Phosphorus and Mg2+
- Albumin
- Acetone
- Serum pH (arterial or venous)
- Serum Na+ levels are not reflected accurately in presence of hyperglycemia
- Evaluation of Serum Sodium (Na+) [5]
- High levels of glucose induce hyponatremia
- This is due primarily to extracellular shift of water since glucose is extracellular
- Laboratory results for serum Na+ levels with hyperglycemia should be adjusted to reflect these fluid shifts (which will reverse as glucose levels drop)
- Classically, adjustment of 1.6 meq/L decrease in Na+ for every 100mg/dL increase in serum glucose (above baseline 100mg/dL) was used
- However, likely that adjustment factor of 2.4meq/L is more appropriate
- For example, if serum glucose is 800mg/dL and reported serum Na+ is 132meq/L, then the corrected serum Na+ level is {(800-100)/100} x 2.4 + 132 = 149meq/L
- The corrected serum Na+ level reflects the true state of hypovolemia
- Evaluation of Hypovolemia [4]
- Physical exam is not sensitive for hypovolemia
- Orthostatic vital sign changes are somewhat helpful
- Pulse increase >30 beats/min is specific but not very sensitive
- Capillary refill time and skin turgor are of no use in adults
- Serum electrolytes, renal function tests, and urine studies are most helpful
- Corrected serum Na+ levels as described above can be used to guide fluid treatment
- Electrocardiogram (ECG)
- Initial evaluation of serum K+ prior to SMA7 data and to rule out cardiac ischemia
- Hyperkalemia due to acidosis and dehydration
- Hypokalemia due to volume (with electrolyte) depletion
- Rule out myocardial infarction and other stresses as precipitant
- Rule out infection as the underlying precipitant
- Chest Radiography
- Urinalysis - UTI is very common in diabetics
- Blood cultures as warranted
- Begin Flow chart of progress
E. Therapeutic Overview
- Replete Intravascular Volume
- Correct Acidosis - insulin and fluids, possible bicarbonate
- Lower Glucose - insulin
- Maintain normal potassium and phosphorus
- Attention to other electrolytes
- Maintain suppression of ketosis - continued insulin ± glucose
F. Intravenous Fluid (IVF)
- Assume hypovolemia deficit 60-70cc/kg (average 3-5 liters deficit; mostly water)
- 1 liter/hr x 2-3 hrs Lactated Ringers or 0.9% (normal) Saline
- Consider addition of Bicarbonate to IVF if pH <7.20
- Monitor FS glucose q hr; when glucose < 300, add D5 (or D10) to IVF
- Serum Na+ results must be corrected for level of hyperglycemia (see above)
G. Insulin [6]
- Given to lower sugar but primarily to suppress ketogenesis
- Initial Dosing
- Bolus of regular insulin 0.1-0.2U/kg intravenously (IV) initially
- Followed by regular insulin 0.1U/kg/hr IV, that is, 5-10U/hr IV (SC is not effective)
- Insulin Lispro can be used subcutaneously (SC)
- Lispro dose is 0.3U/kg SC initially then 0.1U/kg/hour sc until glucose <250mg/dL [8]
- When glucose <250-300, consider starting sc normal insulin <0.25U/kg q4-6 hours or lispro insulin 0.05-0.1 U/kg/hr until resolution of acidosis [8]
- There must be a 60-90 minute overlap between IV and sc insulin (qhr glucose checks)
- If no response to insulin, consider resistance to insulin and increase dose
- Stopping Insulin
- Insulin should be stopped only when pH>7.3, bicarbonate >18mEq/L, acetone is gone
- Monitor serum ketones, but note that ketone test only measures acetoacetate, not ßHB
- Special Settings
- Insulin requirements are much reduced in renal failure (bolus low dose only)
- Insulin requirements are very high in setting of infection, MI, others
H. Potassium
- Average deficit ~4 mmol/kg
- May be elevated initially due to acidosis
- ECG must be obtained early in course
- If ECG shows flat T waves or prominant U waves, add 40mEq/L K+ to initial IVF
- K+ will fall rapidly when pH and volume status are corrected
- Calcium iv should be given in setting of severe hyperkalemia, when ECG changes present
I. Phosphate
- Average deficit ~1mmol/kg
- Hypophosphatemia can cause changed MS, rhabdomyolysis, weakness, hemolysis
- Respiratory failure has also been reported
- Replete very slowly (3-5mmol / hour) iv
- Rapid infusion can cause tonus, vasospasm and arrhythmias (due to Ca2+ binding)
J. Acidosis
- Insulin + fluids will allow body to convert ketoacids to energy forms
- Bicarbonate usually given for pH < 7.20 (controversial as HCO3- may worsen cell acidosis)
- Acidosis with pH < 7.2 can cause respiratory problems and circulatory collapse
- Consider 1 Liter of 1/2NS with 2 Amps sodium bicarbonate added
K. Complications of DKA
- Shock
- Infection: mucormyces is not uncommon following DKA
- Thrombosis
- Respiratory Distress
- Arrhythmias: secondary to electrolyte and acid/base perturbations
- Cerebral Edema (see below)
- Death
L. Cerebral Edema
- Epidemiology
- Rare but dreaded complication of treatment for DKA
- More commonly seen in pediatric than adult patients
- Sub-clinical cerebral edema occurs in majority of patients
- 0.7%-1.0% of pediatric cases develop clinically significant cerebral edema
- Morbidity and Mortality
- Significant morbidity in survivors
- Only 7-14% of patients recover without permanent impairment
- Mortality approaches 50% of symptomatic patients
- Likely present before the initiation of therapy
- Risk Factors [7]
- Aggravated during aggressive rehydration
- Low partial pressures of arterial carbon dioxide (pCO2)
- Elevated serum urea nitrogen (BUN) concentrations
- Treatment with bicarbonate
- Pathophysiology
- Brain cells enzymatically produce idiogenic osmoles in response to hyperosmolar state
- Thus, response to hyperglycemia is to protect against cell shrinkage
- Tight junctions between CNS endothelial cells permit instantaneous water diffusion
- But these junctions retard the rate of solute (Na+, Cl-) diffusion (blood-brain barrier)
- Cerebral edema develops after the initiation of rehydration therapy
- This occurs when serum biochemical indices suggest improvement
- Rapid serum glucose correction decreases serum osmolarity
- Plasma solute becomes lower than spinal fluid solute concentration
- Water without solute diffuses easily into cerebral spinal space
- Intracellular osmoles do not diffuse outward easily and must be enzymatically degraded
- Brain cells accumulate intracellular water (edema) to equalize osmolarity
- Rigid skull results in increased intracranial pressure as volume expands
- Significant cerebral edema can result in herniation of brain stem and cerebral tonsils
- Symptoms
- Related to elevated intracranial pressure
- Headache
- Change in level of consciousness
- Papilledema or unequal dilated pupils
- Vomiting
- Neurological deterioration progresses rapidly if not treated
- Progresses to brain herniation with Cushing Triad:
- Bradycardia
- Elevated blood pressure
- Bradypnea and Respiratory arrest
- New onset polyuria (diabetes insipidus from pituitary necrosis)
- Diagnosis
- Head CT confirms cerebral edema
- Radiologic confirmation of clinical diagnosis not needed to initiate therapy
- Treatment
- Immediate therapy after earliest symptoms maximizes treatment efficacy
- Reduce rate of IVF to about maintenance rates
- Mannitol 1 g/kg IV infusion
- Intubation with hyperventilation
- Note risk factors for cerebral edema above
- Prevention
- Cerebral edema more likely when serum Na+ fails to rise as serum glucose falls
- Use of NS rather than 0.5 NS replacement fluids prevent downward trend in serum Na+
- Correcting total fluid deficits over 48 hour period
- Correct hyperglycemia slowly (< 100 mg/hour)
- Prospective trial showed reduced risk of cerebral edema with slower therapy
- Risk factors suggest minimizing bicarbonate use
M. Hyperosmolar, Hypokalemic, Nonketotic Coma
- Usually occurs in DM2 (and not in Type I DM)
- Enough insulin will lead to suppression of ketolysis
- Failure of sufficient insulin can lead to frank diabetic ketoacidosis
- Patients with DM2 may secrete insulin intermittantly
- However, hyperosmolar state (serum glucose may be >1000mg/dL) develops
- Effects of Hyperosmolarity
- Osmotic diuresis ensues due to high glucose, leading to dehydration
- Potassium and magnesium are lost along with body water and sodium
- Severe dehydration will compromise cardiac perfusion
- High Cardiac Risks: tachycardia from dehydration, low cardiac perfusion, low K+, Mg+
- Impaired cerebral perfusion leads to coma
- Typically triggered by underlying stress
- Infection appears to be most common
- MI or ischemia also not uncommon
- Dietary indiscretion, especially with failure to take medications
- Pancreatitis may precipitate hyperosmolar coma as well
- Treatment
- Fluids usually with insulin as for diabetic ketoacidosis (DKA)
- Very high volumes of fluid usually required (with sodium)
- Fill intravascular space with saline, then correct free water deficit (see below)
- Attention to potassium and phosphate deficit
- Rarely need bicarbonate to reduce acidosis
- Intravenous Fluid Replacement in Hyerosmolar Coma
- Dehydration is the major problem in this state
- Average deficit is 8-10Liters total body fluid depletion; give 1/4 to 1/3 in first 24 hrs
- Calculate fluid deficit based on osmolality of serum
- Correction of problem should begin with >2L of Normal Saline (~2L in first 18-24 hours)
- Calculation of free water deficit: Deficit = BW·[(Na-140)÷ 140] where BW= Body water
- BW = FF·Wt(Kg) where FF= fluid fraction, 0.6 for men, 0.5-0.45 for women, and elderly
- Na (sodium concentration) must be corrected for glucose value (as described above)
- In general, Na drops ~1.6mM for each 100mg/dL glucose value above 100mg/dL
References
- Fleckman AM. 1993. Endocrin Metab Clin N Amer. 22(2):181

- Umpierrez GE, Smiley D, Kitabchi AE. 2006. Ann Intern Med. 144(5):350

- Umpierrez GE, Kelly JP, Navarrete JE, et al. 1997. Arch Intern Med. 157(6):669

- Morris AD, Boyle DIR, McMahon AD, et al. 1997. Lancet. 350(9090):1505

- Hillier TA, Abbott RD, Barrett EJ. 1999. Am J Med. 106(4):399

- Metchick LN, Petit WA Jr, Inzucchi SE. 2002. Am J Med. 113(4):317

- Glaser N, Barnett P, McCaslin I, et al. 2001. NEJM. 344(4):264

- Umpierrez GE, Latif K, Stoever J, et al. 2004. Am J Med. 117(5):291
